KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $59.3 billion.

  • Abbott Laboratories' Non-Current Assets rose 1738.34% to $59.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $234.9 billion, marking a year-over-year increase of 1682.8%. This contributed to the annual value of $57.8 billion for FY2024, which is 1427.27% up from last year.
  • Per Abbott Laboratories' latest filing, its Non-Current Assets stood at $59.3 billion for Q3 2025, which was up 1738.34% from $59.5 billion recorded in Q2 2025.
  • Abbott Laboratories' 5-year Non-Current Assets high stood at $59.5 billion for Q2 2025, and its period low was -$2.9 billion during Q4 2022.
  • Its 5-year average for Non-Current Assets is $47.1 billion, with a median of $50.3 billion in 2021.
  • As far as peak fluctuations go, Abbott Laboratories' Non-Current Assets plummeted by 12203.82% in 2022, and later surged by 185074.47% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Non-Current Assets stood at $13.1 billion in 2021, then crashed by 122.04% to -$2.9 billion in 2022, then surged by 1850.74% to $50.5 billion in 2023, then rose by 14.27% to $57.8 billion in 2024, then rose by 2.74% to $59.3 billion in 2025.
  • Its Non-Current Assets stands at $59.3 billion for Q3 2025, versus $59.5 billion for Q2 2025 and $58.3 billion for Q1 2025.